Reckitt Benckiser Group (OTCMKTS:RBGLY) Rating Increased to Strong-Buy at Barclays

Reckitt Benckiser Group (OTCMKTS:RBGLY - Get Free Report) was upgraded by research analysts at Barclays to a "strong-buy" rating in a report released on Friday, Zacks.com reports.

Get RBGLY alerts:

RBGLY has been the subject of several other reports. UBS Group raised shares of Reckitt Benckiser Group to a "strong-buy" rating in a research note on Wednesday, September 18th. JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group from an "overweight" rating to a "neutral" rating in a research note on Thursday, August 29th. Finally, Citigroup upgraded shares of Reckitt Benckiser Group to a "strong-buy" rating in a report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, five have given a hold rating, one has issued a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy".

Check Out Our Latest Stock Report on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Up 1.3 %

RBGLY stock traded up $0.15 during midday trading on Friday, hitting $12.08. The stock had a trading volume of 311,188 shares, compared to its average volume of 844,680. Reckitt Benckiser Group has a 12-month low of $10.24 and a 12-month high of $15.03. The company's 50-day moving average price is $11.59 and its 200 day moving average price is $11.31.

Ad Crypto 101 Media

Next opportunity for crypto millions

According to Steven Lubka, head of a private equity firm with over $250M in assets under management, "Bitcoin is poised to reach six-figures, no matter who wins the U.S. presidential election…" And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before. Coins that you may not have even heard of before could shoot up 10x, 20x, maybe even 150x in the coming months…

Just click here to request my "Bull Run Millionaire Blueprint" now.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

→ Watch this before it gets removed (From Porter & Company) (Ad)

Should you invest $1,000 in Reckitt Benckiser Group right now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here